FindTrial
Sign In

A phase III, parallel, double-blind, multicenter trial to examine inducible myocardial perfusion abnormality detection with BMS068645 and adenosine stress single photon emission computed tomography SPECT compared to coronary angiography

A phase III, parallel, double-blind, multicenter trial to examine inducible myocardial perfusion abnormality detection with BMS068645 and adenosine stress single photon emission computed tomography SPECT compared to coronary angiography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-001387-31-IT
Enrollment
2000
Registered
2007-01-18
Start date
2006-03-14
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

detection of inducible myocardial perfusion abnormality with stress SPECT MedDRA version: 9.1 Level: HLGT Classification code 10011082 Term: Coronary artery disorders

Interventions

Product Name: BMS-068645 Pharmaceutical Form: Solution for injection CAS Number: 250386-15-3 Current Sponsor code: BMS-068645 Concentration unit: µg microgram(s) Concentration type: equal Concentratio

Sponsors

BRISTOL-M.SQUIBB
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026